Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) is an AI-powered cardiovascular diagnostics company that completed its business combination with Mana Capital Acquisition Corp., sponsored by Mana Capital LLC, in October 2022. The blank-check vehicle had priced its IPO in 2021, targeting the healthcare and life sciences sector. Cardio Diagnostics applies epigenetic and artificial intelligence technology to develop blood-based tests for the early detection of cardiovascular disease, including its lead PrecisionCHD product line. The company filed an 8-K with the SEC on December 19, 2023, under accession number 0001079973-23-001784, reflecting a current reportable event in the post-merger period. Sign up at SpacDesk for full filing history, event timelines, and deep-dive data on CDIO and hundreds of other SPAC transactions.